Burn Pain Market Growth Projections 2024-2034: DelveInsight Analysis | Cumberland Pharma, Janssen R&D, Cephalon

DelveInsight's "Burn Pain Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Burn Pain, historical and forecasted epidemiology as well as the Burn Pain market trends in the United States, EU4 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

To Know in detail about the Burn Pain market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Burn Pain Market Forecast
https://www.delveinsight.com/sample-request/burn-pain-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key facts of the Burn Pain Market Report:
• The Burn Pain market size is anticipated to grow with a significant CAGR during the study period (2020-2034)
• In August 2024, MediWound Ltd. (Nasdaq: MDWD), a global leader in enzymatic therapeutics for tissue repair, announced that the U.S. Food and Drug Administration (FDA) has approved NexoBrid® (anacaulase-bcdb) for eschar removal in pediatric patients from newborns to 18 years old with deep partial- and full-thickness thermal burns. This approval expands NexoBrid's authorization for all age groups in the U.S., aligning with its approvals in the European Union and Japan.
• In 2023, the US maintained the largest market share among the 7MM, reaching USD 140 million. Projections indicate that this trend will persist, with the US expected to further strengthen its market dominance and remain the leading player by 2034.
• In 2023, Germany and the UK in the EU4 and the UK both achieved market shares exceeding USD 20 million, with France following closely behind. In contrast, Italy had the smallest market share among these regions during the same period.
• Opioid analgesics dominated the current treatment market for both inpatient and outpatient care, with an estimated market value of approximately USD 130 million in 2023.
• In 2023, the US recorded over 2 million incident cases of burns, with numbers expected to rise by 2034.
• In 2023, approximately 0.4 million treated incident burn cases requiring pain management therapies were reported in the US, with expectations for change during the study period from 2020 to 2034.
• The gender distribution indicates a male dominance across the 7MM, with around 0.29 million male cases and 0.26 million female cases reported in the US in 2023.
• Key Burn Pain Companies: Medical Developments International, Cumberland Pharmaceuticals, Janssen Research & Development, Cephalon, and others
• Key Burn Pain Therapies: Methoxyflurane (PENTHROX), Caldolor, JNJ-42160443, ACTIQ, and others
• The Burn Pain epidemiology based on etiology-specific cases analyzed that Etiology Specific Incident Cases of Burns is classified into Flame, Contact, Scald, Electrical, Chemical, and Others
• The Burn Pain market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Burn Pain pipeline products will significantly revolutionize the Burn Pain market dynamics.

Burn Pain Overview
Burn pain refers to the intense and often prolonged pain experienced following a burn injury. It can result from damage to the skin and underlying tissues caused by heat, chemicals, electricity, or radiation. Burn pain can be acute, occurring immediately after the injury, or chronic, persisting during the healing process or due to nerve damage. It is typically managed through a combination of pain relievers, wound care, and sometimes psychological support, depending on the severity of the burn. Effective pain management is crucial for healing and improving quality of life in burn patients.

Get a Free sample for the Burn Pain Market Report -
https://www.delveinsight.com/report-store/burn-pain-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Burn Pain Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Burn Pain Epidemiology Segmentation:
The Burn Pain market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
• Total Prevalence of Burn Pain
• Prevalent Cases of Burn Pain by severity
• Gender-specific Prevalence of Burn Pain
• Diagnosed Cases of Episodic and Chronic Burn Pain

Download the report to understand which factors are driving Burn Pain epidemiology trends @ Burn Pain Epidemiology Forecast
https://www.delveinsight.com/sample-request/burn-pain-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Burn Pain Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Burn Pain market or expected to get launched during the study period. The analysis covers Burn Pain market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Burn Pain Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Burn Pain Therapies and Key Companies
• Methoxyflurane (PENTHROX): Medical Developments International
• Caldolor: Cumberland Pharmaceuticals
• JNJ-42160443: Janssen Research & Development
• ACTIQ: Cephalon

Discover more about therapies set to grab major Burn Pain market share @ Burn Pain Treatment Market
https://www.delveinsight.com/sample-request/burn-pain-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Burn Pain Market Strengths
• The increasing incidence of patients with burns is expected to propel the treatment market in the future, adding opportunities for new pharma players

Burn Pain Market Opportunities
• The rising incidence of burn pain indicates increasing pharmacological treatment demands, thereby crafting lucrative opportunities for new pharma players

Scope of the Burn Pain Market Report
• Study Period: 2020-2034
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Burn Pain Companies: Medical Developments International, Cumberland Pharmaceuticals, Janssen Research & Development, Cephalon, and others
• Key Burn Pain Therapies: Methoxyflurane (PENTHROX), Caldolor, JNJ-42160443, ACTIQ, and others
• Burn Pain Therapeutic Assessment: Burn Pain current marketed and Burn Pain emerging therapies
• Burn Pain Market Dynamics: Burn Pain market drivers and Burn Pain market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Burn Pain Unmet Needs, KOL's views, Analyst's views, Burn Pain Market Access and Reimbursement

To know more about Burn Pain companies working in the treatment market, visit @ Burn Pain Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/burn-pain-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Burn Pain Market Report Introduction
2. Executive Summary for Burn Pain
3. SWOT analysis of Burn Pain
4. Burn Pain Patient Share (%) Overview at a Glance
5. Burn Pain Market Overview at a Glance
6. Burn Pain Disease Background and Overview
7. Burn Pain Epidemiology and Patient Population
8. Country-Specific Patient Population of Burn Pain
9. Burn Pain Current Treatment and Medical Practices
10. Burn Pain Unmet Needs
11. Burn Pain Emerging Therapies
12. Burn Pain Market Outlook
13. Country-Wise Burn Pain Market Analysis (2020-2034)
14. Burn Pain Market Access and Reimbursement of Therapies
15. Burn Pain Market Drivers
16. Burn Pain Market Barriers
17. Burn Pain Appendix
18. Burn Pain Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Related Reports:

Burn Pain Epidemiology https://www.delveinsight.com/report-store/burn-pain-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Burn Pain Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Burn Pain epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Latest Reports by DelveInsight
• Acute Radiation Syndrome Market: https://www.delveinsight.com/report-store/acute-radiation-syndrome-pipeline-insight
• Human Papillomavirus Hpv Market: https://www.delveinsight.com/report-store/human-papillomavirus-hpv-market
• Blood Gas And Electrolyte Analyzers Market: https://www.delveinsight.com/report-store/blood-gas-and-electrolyte-analyzers-market
• Interspinous Spacers Market: https://www.delveinsight.com/report-store/interspinous-spacers-market
• Dengue Fever Market: https://www.delveinsight.com/report-store/dengue-fever-market
• Chronic Hemodialysis Market: https://www.delveinsight.com/report-store/chronic-hemodialysis-market
• Brucellosis Market: https://www.delveinsight.com/report-store/brucellosis-market

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting

About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

This release was published on openPR.